Stephanie Vauleon
Overview
Explore the profile of Stephanie Vauleon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kholmanskikh O, Wang Y, Hersey S, Wadhwa M, Block K, Bandukwala A, et al.
Bioanalysis
. 2024 Jun;
16(8):179-220.
PMID: 38899739
The 17 Workshop on Recent Issues in Bioanalysis (17 WRIB) took place in Orlando, FL, USA on 19-23 June 2023. Over 1000 professionals representing pharma/biotech companies, CROs, and multiple regulatory...
2.
Godfrey J, Gao L, Shouse G, Song J, Pak S, Lee B, et al.
Blood
. 2024 Mar;
144(4):457-461.
PMID: 38484137
Although CD20×CD3 bispecific antibodies are effective against systemic B-cell lymphomas, their efficacy in central nervous system (CNS) lymphoma is unknown. Here, we report the CD20×CD3 bispecific glofitamab penetrates the blood-brain...
3.
Vauleon S, Schutz K, Massonnet B, Gruben N, Manchester M, Buehler A, et al.
Sci Rep
. 2023 Apr;
13(1):5332.
PMID: 37005488
Huntington's disease (HD) is caused by a cytosine adenine guanine-repeat expansion in the huntingtin gene. This results in the production of toxic mutant huntingtin protein (mHTT), which has an elongated...
4.
Ivens I, Banczyk D, Gutberlet K, Jackman S, Vauleon S, Frisk A
Toxicol Pathol
. 2019 May;
47(5):585-597.
PMID: 31132933
BAY 94-9027 (Jivi) is a site-specifically PEGylated human B-domain-deleted (BDD) recombinant factor VIII (FVIII), with a 60 kDa branched PEG molecule attached. The nonclinical safety of BAY 94-9027 was evaluated...
5.
Steurer M, Montillo M, Scarfo L, Mauro F, Andel J, Wildner S, et al.
Haematologica
. 2019 May;
104(10):2053-2060.
PMID: 31097627
Olaptesed pegol (NOX-A12) is a pegylated structured L-oligoribonucleotide that binds and neutralizes CXCL12, a chemokine tightly regulating the life cycle of chronic lymphocytic leukemia cells. The resulting inhibition of CXCR4...
6.
van Eijk L, John A, Schwoebel F, Summo L, Vauleon S, Zollner S, et al.
Blood
. 2014 Aug;
124(17):2643-6.
PMID: 25163699
Increased hepcidin production is key to the development of anemia of inflammation. We investigated whether lexaptepid, an antihepcidin l-oligoribonucleotide, prevents the decrease in serum iron during experimental human endotoxemia. This...
7.
Drude I, Vauleon S, Muller S
Biochem Biophys Res Commun
. 2007 Sep;
363(1):24-9.
PMID: 17825791
Over the past two decades, the structure and mechanism of catalytic RNA have been extensively studied; now ribozymes are understood well enough to turn them into useful tools. After we...
8.
Pieper S, Vauleon S, Muller S
Biol Chem
. 2007 Jun;
388(7):743-6.
PMID: 17570827
Reversible chemistry, allowing for chain-forming as well as chain-breaking steps, is important for biological self-organization. In this context, ribozymes, catalyzing both RNA cleavage and ligation, may have significantly contributed to...
9.
Vauleon S, Ivanov S, Gwiazda S, Muller S
Chembiochem
. 2005 Nov;
6(12):2158-62.
PMID: 16276501
No abstract available.
10.
Ivanov S, Vauleon S, Muller S
FEBS J
. 2005 Sep;
272(17):4464-74.
PMID: 16128815
In recent years major progress has been made in elucidating the mechanism and structure of catalytic RNA molecules, and we are now beginning to understand ribozymes well enough to turn...